Regulation 3 Amendment of the Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019I1
United Kingdom
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019 M1 are amended in accordance with Schedule 1.
Annotations
Marginal citations
- M1
Commencement
- I1
Reg. 3 in force at 31.12.2020 immediately before IP completion day, see reg. 1